AI-based glaucoma screening at health centers
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are African American or Hispanic and age 40 or older
- You are non-Hispanic white and age 50 or older
- You are 18 or older and have type 1 or type 2 diabetes
- You are 18 or older and already have a condition related to glaucoma
- You are 18 or older and have a family member with glaucoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI-based system to check for diabetic retinopathy during regular eye exams at primary care clinics. It may help catch vision problems early if you have diabetes.
This study tests an artificial intelligence (AI) system that looks at eye images to find early signs of glaucoma, a condition that can damage the optic nerve and lead to vision loss. The goal is to see if the AI can accurately tell apart people with glaucoma from those with healthy eyes, which could help with earlier diagnosis and treatment.
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
This study is testing an artificial intelligence tool that can automatically detect signs of glaucoma in photos of the retina. It may help confirm that the AI can accurately identify glaucoma, which could lead to faster diagnosis and monitoring for patients.
This trial uses artificial intelligence to help diagnose eye conditions from digital eye images. If you have certain types of eye images from regular check-ups, your data might help teach the AI to recognise diseases better.
This study tests whether artificial intelligence can help detect early signs of diabetes-related eye damage before vision loss happens. You'd be screened at your regular doctor visit using a new AI tool, which could catch problems earlier than usual.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.